Transforming the production method of life-saving pharmaceuticals
ExCulture has an exclusive licence to a mixed culture fermentation bioprocess technology from TU Delft that we are developing as a novel method for producing heparin-like compounds.
To future-proof the supply chains of life-saving medications such as heparin through the implementation of a bio-based, animal-free approach.
Eliminates the dependency on animal products
Is a natural, sustainable production method for the recovery of scarce high-value material (including heparin-like compounds) from abundant sources
Has high scalability potential
Is not dependent on geographical location